Viral Infection of HSPC Impacts Hematopoiesis

Abroad (travel likely)Recruiting

Conditions

HIV-1 · SARS-CoV-2

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Hematology and interne medicine department, Ambroise Paré hospital - APHP, Boulogne-Billancourt, France

Study leads

Claude CAPRON, MD, PhD
Principal Investigator
Laboratory of Immunology, Ambroise Paré hospital - APHP
Fernando REAL, PhD
Study Director
Center for Infection and Immunity of Lille, INSERM U1019 - CNRS UMR9017, Institut Pasteur de Lille

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption

HIV

Abroad (travel likely)RecruitingPHASE2

Bethesda, United States

REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE

HIV -1 Infection · HIV (Human Immunodeficiency Virus) · HIV

Abroad (travel likely)RecruitingPHASE4

Clearwater, United States · Ft. Pierce, United States

A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments

HIV-1-infection

Abroad (travel likely)RecruitingPHASE4

Buenos Aires, Argentina · Panama City, Panama

Long-Acting Cabotegravir and Rilpivirine in People Living With HIV-1 Subtype A6: A Real-World Retrospective Study

Human Immunodeficiency Virus (HIV)-1 Infection · HIV-1 Subtype A6 Infection · HIV-1 Subtype B Infection

Abroad (travel likely)Recruiting

Prague, Czechia · Frankfurt, Germany